
Pantonim IV 40mg Injection
Marketer
Eustoma Laboratories Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Pantonim IV 40mg Injection
AcidGard 40mg intravenous injection diminishes gastric acid production. It treats acid-related gastrointestinal disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, alleviating symptoms and fostering healing. AcidGard 40mg is also prophylactic against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. A proton pump inhibitor (PPI), it's intravenously administered by a healthcare provider only when deemed superior to oral forms. Dosage varies based on individual needs and response; treatment duration is determined by your physician and should be completed as directed, even with rapid symptom resolution. Optimal results are achieved by consuming smaller, more frequent meals and avoiding caffeinated beverages, spicy foods, and high-fat items. Common, generally mild, side effects comprise nausea, vomiting, headache, vertigo, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects necessitate medical attention. Prolonged use may increase adverse event risk; prolonged therapy exceeding one year elevates bone fracture risk, particularly at higher doses. Discuss bone health maintenance strategies, including calcium and vitamin D supplementation, with your doctor. AcidGard 40mg is contraindicated in certain individuals. Inform your physician of severe hepatic impairment, concurrent HIV medication use, prior allergic reactions to similar medications, or pre-existing osteoporosis before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or somnolence occurs.
Uses of Pantonim IV 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantonim IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Pantonim IV 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantonim IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pantonim IV 40mg Injection works:
Pantoloc IV 40mg injection, a proton pump inhibitor, decreases stomach acid production, thereby alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while using Pantonim IV 40mg Injection.
PregnancyCONSULT YOUR DOCTOR
Administering Pantonim IV 40mg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
The administration of Pantonim IV 40mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Pantonim IV 40mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Pantonim IV 40mg Injection is considered safe and requires no dosage modification.
LiverCAUTION
Administering Pantonim IV 40mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification of Pantonim IV 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Pantonim IV 40mg Injection :
Omitting a scheduled dose of Pantonim IV 40mg Injection warrants immediate physician consultation.
Facts to Know About Pantonim IV 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
